Literature DB >> 22970697

Prevalence of the primary LHON mutations in Northern Finland associated with bilateral optic atrophy and tobacco-alcohol amblyopia.

Paula Korkiamäki1, Marko Kervinen, Karoliina Karjalainen, Kari Majamaa, Johanna Uusimaa, Anne M Remes.   

Abstract

PURPOSE: Leber hereditary optic neuropathy (LHON) is regarded as the most common mitochondrial disease. We have previously reported comprehensive population-based epidemiological data on common mitochondrial DNA (mtDNA) mutations including m.3243A>G, m.8344A>G and large-scale mtDNA deletions in Northern Finland. Our aim was to investigate the prevalence of primary LHON mutations and mutations in the four mtDNA genes considered hot spots for LHON in the same population.
METHODS: The study population consisted of 42 adult patients with an aetiologically undefined bilateral optic atrophy. The major LHON mutations m.3460G>A, m.11778G>A and m.14484T>C were analysed by restriction fragment length polymorphism (RFLP), and MTND1, MTND6 and MTATP6 genes were sequenced. MTND5 gene was analysed by conformation-sensitive gel electrophoresis (CSGE).
RESULTS: No major LHON mutations were found in the population of the province of Northern Ostrobothnia giving the prevalence of these mutations 0-1.36:100 000 (95% CI). However, two main mutations were found elsewhere in Northern Finland, homoplasmic m.11778G>A from Kainuu and heteroplasmic m.3460G>A from Central Ostrobothnia. Furthermore, tobacco-alcohol amblyopia was diagnosed in five patients in the study population and one of them had m.11778G>A.
CONCLUSION: The prevalence of the three major LHON mutations is lower in Northern Finland than elsewhere in Finland or in Western Europe. As LHON and tobacco-alcohol amblyopia have a similar phenotype, we recommend analysing the known LHON-associated mutations before setting tobacco-alcohol amblyopia diagnosis.
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  Tobacco-alcohol amblyopia; genetics; leber hereditary optic neuropathy (LHON); mtDNA; prevalence

Mesh:

Substances:

Year:  2012        PMID: 22970697     DOI: 10.1111/j.1755-3768.2012.02506.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  A Meta-analysis of the association between different genotypes (G11778A, T14484C and G3460A) of Leber hereditary optic neuropathy and visual prognosis.

Authors:  Dong-Yu Guo; Xia-Wei Wang; Nan Hong; Yang-Shun Gu
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

2.  Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy.

Authors:  Martina Jarc-Vidmar; Mojca Tajnik; Jelka Brecelj; Ana Fakin; Maja Sustar; Mateja Naji; Branka Stirn-Kranjc; Damjan Glavač; Marko Hawlina
Journal:  Doc Ophthalmol       Date:  2015-02-19       Impact factor: 2.379

Review 3.  Leber's hereditary optic neuropathy is multiorgan not mono-organ.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Clin Ophthalmol       Date:  2016-11-02

4.  Generation and Bioenergetic Profiles of Cybrids with East Asian mtDNA Haplogroups.

Authors:  Huaibin Zhou; Ke Nie; Ruyi Qiu; Jingting Xiong; Xiaoli Shao; Bingqian Wang; Lijun Shen; Jianxin Lyu; Hezhi Fang
Journal:  Oxid Med Cell Longev       Date:  2017-09-28       Impact factor: 6.543

5.  Whole Mitochondrial Genome Analysis in Serbian Cases of Leber's Hereditary Optic Neuropathy.

Authors:  Phepy G A Dawod; Jasna Jancic; Ana Marjanovic; Marija Brankovic; Milena Jankovic; Janko Samardzic; Dario Potkonjak; Vesna Djuric; Sarlota Mesaros; Ivana Novakovic; Fayda I Abdel Motaleb; Vladimir S Kostic; Dejan Nikolic
Journal:  Genes (Basel)       Date:  2020-09-02       Impact factor: 4.096

Review 6.  The Role of Mitonuclear Incompatibility in Bipolar Disorder Susceptibility and Resilience Against Environmental Stressors.

Authors:  Suzanne Gonzalez
Journal:  Front Genet       Date:  2021-03-16       Impact factor: 4.599

7.  Whole mitochondrial genome sequencing of Malaysian patients with cardiomyopathy.

Authors:  Sheh Wen Kuan; Kek Heng Chua; E-Wei Tan; Lay Koon Tan; Alexander Loch; Boon Pin Kee
Journal:  PeerJ       Date:  2022-04-14       Impact factor: 3.061

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.